Skip to content
Home/Companies/MedTech/CellQuest

CellQuest

MedTech·France·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns CellQuest?

CellQuest is currently owned by ANGELOR through Angelor (2014 vintage), since 2023.

Hand-verified · updated 2026-04-21

ANGELOR
Investor
ANGELOR
Angelor · 2014 · VC

Key facts

HQFrance
SectorMedTech

More from Angelor

Other portfolio companies in the same fund.

Axoltis Pharma
Axoltis Pharma
Active
BiotechFrance· 2024
Brenus Pharma
Brenus Pharma
Active
BiotechFrance· 2024
Dillico
Dillico
Active
BiotechFrance· 2024
Hawk Cell
Hawk Cell
Active
BiotechFrance· 2024
Pixee Medical
Active
MedTechFrance· 2024
Standing Ovation
Active
BiotechFrance· 2024

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track CellQuest

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy CellQuest?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on CellQuest.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue